Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Oncolytics Biotech Inc T.ONC

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ONCY

Oncolytics Biotech, Inc., is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers.
Price: $1.52 | Change: +$0.01 | %Change: +0.66%
Volume: 25,500 | Day High/Low: 1.54/1.49 | 52 Week High/Low: 3.62/1.31


Last Traded: July 30, 2014 10:57 Transaction Volume: 24,300
Open: $1.52 Previous Close: $1.51
Bid: $1.52 Ask: $1.54
Bid Size: 1,200 Ask Size: 1,800
Market Cap: $133.1m Shares Out: 87.5m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts


Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Latest Bullboard Posts

  • RE:Reading between the lines!

    5 stars

    I continue to buy ONC, even though I have a lot of shares, because the risk/reward ratio is so high. I have never before been in a stock...

    2 stars

  • Reading between the lines!

    4 stars

    The comments below by Dr Saab indicates he has seen highly positive results from this Phase 2 trial. As the PI of the trial his comments...

    2.5 stars

  • More positive news from Dr Saab

    5 stars

    Originally published: Jul 24 2014 - 1:00pm By: Karin Heineman, Executive Producer (Inside Science TV) – In 2013, Barbara Williams was...

    2.5 stars

  • Discussion Topics & Possible Outcomes

    0.5 stars

    Cardu, your June 19th post is out of character. It’s more in keeping with something that Cravenraven would post. Your post of comments by...

    1 star

  • A few comments from Dr. Saab

    5 stars

    Saab said the results have been amazing so far, both slowing cancer growth and reducing the size of the tumor. It leaves healthy cells...

    2.5 stars